Cytogenetic follow-up by karyotyping and fluorescence in situ hybridization: implications for monitoring patients with myelodysplastic syndrome and deletion 5q treated with lenalidomide.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples